ZeCardio Therapeutics (ZeCardioTx), a pharma company focused on the discovery of cardiovascular drugs using the zebrafish model and a proprietary screening platform, ZeCardio®, selected Taros’ SVP Drug Discovery, Dr. Torsten Hoffmann, to join…
Press releases
Communication is key to success, this is also true for science
Stay updated with the most recent developments and activities at Taros by reading our press releases.
Looks interesting?
As a leading contract research organization in discovery chemistry and custom synthesis, Taros provides comprehensive solutions to meet our clients’ needs from diverse branches and applications
Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.
